Massachusetts Financial Services
RCUS icon

Massachusetts Financial Services’s Arcus Biosciences RCUS Stock Holding History

Massachusetts Financial Services’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$671K Sell
21,750
-867
-4% -$21.4K ﹤0.01% 926
2026
Q1 		$489K Sell
22,617
-599
-3% -$12.9K ﹤0.01% 897
2025
Q4 		$553K Sell
23,216
-769
-3% -$15.7K ﹤0.01% 867
2025
Q3 		$326K Buy
23,985
+1,577
+7% +$16.4K ﹤0.01% 842
2025
Q2 		$182K Sell
22,408
-54,386
-71% -$465K ﹤0.01% 874
2025
Q1 		$603K Sell
76,794
-1,750
-2% -$20.3K ﹤0.01% 838
2024
Q4 		$1.17M Sell
78,544
-2,345
-3% -$38.3K ﹤0.01% 808
2024
Q3 		$1.24M Buy
80,889
+22,716
+39% +$358K ﹤0.01% 781
2024
Q2 		$886K Buy
58,173
+1,951
+3% +$31.5K ﹤0.01% 805
2024
Q1 		$1.06M Sell
56,222
-124
-0.2% -$2.14K ﹤0.01% 784
2023
Q4 		$1.08M Sell
56,346
-1,780
-3% -$28.4K ﹤0.01% 769
2023
Q3 		$1.04M Sell
58,126
-2,227
-4% -$44.7K ﹤0.01% 762
2023
Q2 		$1.23M Sell
60,353
-1,422
-2% -$27.1K ﹤0.01% 737
2023
Q1 		$1.13M Buy
+61,775
New +$1.18M ﹤0.01% 750

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Massachusetts Financial Services's RCUS Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Arcus Biosciences (RCUS) stake by 3.8% in Q2 2026, selling an estimated $21.4K and leaving 21,750 shares worth $671K. The position accounts for ﹤0.01% of the portfolio, ranked #926.

Massachusetts Financial Services first reported a position in RCUS in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.24M in Q3 2024. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Massachusetts Financial Services held 21,750 shares of Arcus Biosciences worth $671K as of Q2 2026.
  • Massachusetts Financial Services sold 867 Arcus Biosciences shares in Q2 2026, an estimated $21.4K.
  • Arcus Biosciences made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #926 holding.
  • Massachusetts Financial Services first reported a position in Arcus Biosciences in Q1 2023 and has held it in 14 quarters since.
  • Massachusetts Financial Services's Arcus Biosciences position peaked at $1.24M in Q3 2024.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.